Attached files
| file | filename |
|---|---|
| EX-99.1 - Eloxx Pharmaceuticals, Inc. | v200577_ex99-1.htm |
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
_______________________________
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES
EXCHANGE ACT OF 1934
Date of
report (Date of earliest event reported): October 29,
2010
Senesco
Technologies, Inc.
(Exact
Name of Registrant as Specified in Charter)
|
Delaware
|
001-31326
|
84-1368850
|
|
(State
or Other Jurisdiction
of
Incorporation)
|
(Commission
File Number)
|
(IRS
Employer Identification No.)
|
|
303
George Street, Suite 420, New Brunswick, New Jersey
|
08901
|
|
(Address
of Principal Executive Offices)
|
(Zip
Code)
|
|
(732)
296-8400
|
|
(Registrant's
telephone number,
including
area code)
|
Not
applicable
(Former
Name or Former Address, if Changed Since Last Report)
Check the
appropriate box below if the Form 8-K is intended to simultaneously satisfy
the filing obligation of the registrant under any of the following
provisions:
o Written
communications pursuant to Rule 425 under the Securities Act
(17 CFR 230.425).
o Soliciting
material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12).
o Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act
(17 CFR 240.14d-2(b)).
o Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act
(17 CFR 240.13e-4(c)).
Item
8.01. Other Events.
On
October 29, 2010, Senesco Technologies, Inc., a Delaware corporation (the
“Company”), received a notice from NYSE Amex LLC (“NYSE Amex”) indicating that
the Company again satisfies Section 1003(a)(iii) of the NYSE Amex Company Guide
for continued listing on NYSE Amex as the Company has regained a minimum
stockholders' equity of $6,000,000. As reported in its recently filed
Annual Report on Form 10-K for the period ended June 30, 2010, the Company
reports stockholders' equity of $7,981,024.
A copy of
the press release announcing that the Company has regained compliance with NYSE
Amex continued listing requirements is attached hereto as Exhibit 99.1 and is
incorporated by reference herein.
Item
9.01. Financial Statements and Exhibits.
(d) Exhibits.
|
Exhibit No.
|
Description
|
|
|
99.1
|
Press
Release dated November 2, 2010
|
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned, hereunto
duly authorized.
|
|
SENESCO
TECHNOLOGIES, INC.
|
|
Dated:
November 2, 2010
|
By:
/s/ Leslie J. Browne,
Ph.D.
|
|
Name:
Leslie J. Browne, Ph.D.
|
|
|
Title:
President and Chief Executive
Officer
|